U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 200 points on Wednesday.

Shares of Qorvo, Inc. (NASDAQ:QRVO) fell sharply in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter sales guidance below estimates.

Qorvo shares expects fiscal fourth-quarter revenue to be in the range of $775 million to $825 million versus estimates of $904.59 million. The company anticipates adjusted earnings of $1.05 to $1.35 per share in the fourth quarter versus estimates of $1.37 per share.

Qorvo shares dipped 10.5% to $74.11 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Virtuix Holdings Inc. (NASDAQ:VTIX) shares dipped 22.1% to $18.99 in pre-market trading after jumping 22 on Tuesday.
• Altimmune, Inc. (NASDAQ:ALT) fell 15.8% to $5.20 in pre-market trading after the company announced pricing of $75 million registered direct offering of common stock.
• Elevra Lithium Limited (NASDAQ:ELVR) declined 10.8% to $56.50 in pre-market trading. Elevra Lithium reported December quarter revenue of $66 million.
• United Microelectronics Corporation (NYSE:UMC) shares dipped 9.9% to $11.26 in pre-market trading after reporting fourth-quarter results.
• Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) fell 9.6% to $21.19 in pre-market trading.
• Skyworks Solutions, Inc. (NASDAQ:SWKS) dipped 9.2% to $54.50 in pre-market trading.
• Elevance Health, Inc. (NYSE:ELV) declined 6.7% to $301.29 in pre-market trading following weak quarterly sales.
• StandardAero, Inc. (NYSE:SARO) dipped 6.4% to $30.98 in pre-market trading after the company reported preliminary FY25 revenue and filed a prospectus to sell 187,137,524 shares. Also, the company announced an offering of 50 million shares.
• MSCI Inc. (NYSE:MSCI) fell 3.6% to $560.22 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.